The Use of Cord Blood Stem Cells in Clinical Practice

Abstract

Here we review general achievements in cord blood (as well as the cord) stem cells use. In two main part of the review we discuss the clinical experience of progenitors from cord blood in treatment of oncology and other diseases.

The major results of clinical trials in children and adult patients are briefly presented in several tables. Besides, there are two parts dedicated to some difficulties and problems, connected with the use of cord blood stem cells and to general perspective trends ofcord blood cells clinical use.

Keywords

cord blood / stem cells / clinical trials

References

[1] Gluckman Е., Broxmeyer Н.А., Auerbach A.D. et al. Hematopoietic reconstitution in a patient with Fanconi's anemia by means of umbilical-cord blood from an HLA-identical sibling. New England Journal of Medicine 1989; 321:117478.

[2] Rubinstein P. Why Cord Blood? Human Immunology 2006; 67:398-404.

[3] Rocha V, Gluckman E. Clinical use of umbilical cord blood hematopoietic stem cells. Biol Blood Marrow Transplant 2006; 12 [Suppl 1): 34-41.

[4] Wagner J.E., Barker J.N., DeFor T.E. et al.Transplantation of unrelated donor umbilical cord blood in 102 patients with malignant and nonmalignant diseases: influence of CD34 cell dose and HLA disparity on treatment-related mortality and survival. Blood 2002; 100:1611-18.

[5] http: / / www.clinicaltrials.gov / ct/ search;jsessmd=D1645713FDOR38568A149DFE87E66A1E?tErm=cordtblood8submi?Search

[6] Yahata T., Ando K., Sato T., et al. A highly sensitive strategy for SCID repopulating cell assay by direct injection of primitive human hematopoietic cells into NOD/SCID mice bone marrow. Blood 2003; 101: 2905-13.

[7] Kim D.W., Chung Y.J., Kim T.G., et al. Cotransplantation of third-party mesenchymal stromal cells can alleviate single-donor predominance and increase engraftment from double cord transplantation. Blood 2004; 103:1941-48.

[8] Kurtzberg J., Graham M., Casey J., et al. The use of umbilical cord blood in mismatched related and unrelated hemopoietic stem cell transplantation. Blood Cells 1994; 20:275.

[9] Rubinstein P., Eapen M., Stevens C.E., et al. Unrelated donor hematopoietic transplantation [HSCT) in children with acute leukemia: risks and benefits of unrelated cord blood [CB) vs. Bone Marrow [BM). Blood 2005; 106 [Abstract 3020).

[10] Kernan N.A., Carter S.L., Wagner J.E. et al.Umbilical cord blood transplantation in pediatric patients: results of a prospective, Multi-Institutional Cord Blood Transplantation Study. Biology of Blood and Marrow Transplantation 2006; 12:14.

[11] Arcese W., Rocha V., Labopin M. et al. Unrelated cord blood transplants in adults with hematologic malignancies. Haematologica 2006; 91: 223-230.

[12] Rocha V.& Gluckman E. Clinical use of umbilical cord blood hematopoietic stem cells. Biology of Blood and Marrow Transplantation 2006; 12: 34-41.

[13] Rubinstein P., Carrier C., Scaradavou A. et al. Outcomes among 562 recipients of placental-blood transplants from unrelated donors. New England Journal of Medicine 1998; 339:1565-77.

[14] Ooi J., Iseki T., Nagayama H. et al. The efficacy of unrelated cord blood transplantation for adult myelodysplastic syndrome. Leukemia & Lymphoma 2006; 47: 599-602.

[15] Majhail N.S., Weisdorf D.J., Wagner J.E. et al. Comparable results of umbilical cord blood and HLA-matched sibling donor hematopoietic stem cell transplantation after reduced-intensity preparative regimen for advanced Hodgkin lymphoma. Blood 2006; 107: 3804-07.

[16] Brunstein C. G., Barker J. N., Weisdorf D.J. et al. Umbilical Cord Blood Transplantation after Nonmyeloablative Conditioning: Impact on Transplant Outcomes in 110 Adults with Hematological Disease. Blood 2007; 110(8): 3064-70.

[17] Mao P., WangS., Zhu Z. etal. Umbilical cord blood transplantforadult patients with severe aplastic anemia using anti-lymphocyte globulin and cyclophosphamide as conditioning therapy. Bone Marrow Transplantation 2004; 33: 33-8.

[18] Adamkiewicz T.V., Szabolcs P., Haight A. et al. Unrelated cord blood transplantation in children with sickle cell disease: Review of four-center experience. Pediatr Transplantation 2007; 11: 641-44.

[19] Gluckman E. Cord blood transplantation. Biology of Blood and Marrow Transplantation 2006; 12: 808-12.

[20] EscolarM.L., PoeM.D., Provenzale J.M. et al. Transplantation of umbilicalcord blood in babies with infantile Krabbe's disease. New England Journal of Medicine 2005; 352: 2069-81.

[21] Staba S.L., Escolar M.L., Poe M. et al. Cord-blood transplants from unrelated donors in patients with Hurler's syndrome. New England Journal of Medicine 2004; 350:1960-69.

[22] Martin P.L., Carter S.L., Kernan N.A. et al. Results of the cord blood transplantation study [COBLT): outcomes of unrelated donor umbilical cord blood transplantation in pediatric patients with lysosomal and peroxisomal storage diseases. Biology of Blood and Marrow Transplantation 2006; 12:184-94.

[23] Bhattacharya A., Slatter M.A., Chapman C.E. et al. Single centre experience of umbilical cord stem cell transplantation for primary immunodeficiency. Bone Marrow Transplantation 2005; 36: 295-99.

[24] Kobayashi R., Ariga T., Nonoyama S. et al. Outcome in patients with Wiskott-Aldrich syndrome following stem cell transplantation: an analysis of 57 patients in Japan. British Journal of Haematology 2006; 135: 362-66.

[25] JaingT-H., Tsai В-Y., Chen S-H. etal. Early transplantation of unrelated cord blood in a two-month-old infant with Wiskott-Aldrich syndrome. Pediatr Transplantation 2007; 11: 557-9.

[26] Hayani A., Lampeter E., Viswanatha D. et al. First Report of Autologous Cord Blood Transplantation in the Treatment of a Child With Leukemia. Pediatrics 2007; 119: 296-300.

[27] Kogler G., Sensken S., Airey J. A. et al. A new human somatic stem cell from placental cord blood with intrinsic pluripotent differentiation potential. J Exp Med 2004; 200:123-135.

[28] Hall J., Crapnell K.B., Staba S. et al. Isolation of oligodendrocyte precursors from umbilical cord blood. Biol. Blood Marrow Transplant 2004; 10: 67.

[29] Crapnell K.B., Turner K., Hall J.G. et al. Umbilical cord blood cells engraft and differentiate in cardiac tissues after human transplantation. Blood 2003; 102:153.

[30] Moelker A.D., Baks T., Wever K.M. et al. Intracoronary delivery of umbilical cord blood derived unrestricted somatic stem cells is not suitable to improve LV function after myocardial infarction in swine. J. Mol. Cell Cardiol. 2007; 42(4): 735-45.

[31] Wu K.H., Zhou B., Yu C. Y. et al. Therapeutic Potential of Human Umbilical Cord Derived Stem Cells in a Rat Myocardial nfarction Model. Ann. Thorac. Surg 2007; 83 :1491-500.

[32] Nishiyama N., Miyoshi S., Hida N. et al. The Significant Cardiomyogenic Potential of Human Umbilical Cord Blood-Derived Mesenchymal Stem Cells In Vitro. Stem Cells 2007; 25 [8).

[33] Prat-Vidal C., RouraS., Farre J. etal. Umbilical cord blood-derived stem cells spontaneously express cardiomyogenic traits. Transplant .Proc .2007; 39(7): 2434-7.

[34] Leor J., Guetta E., Feinberg M.S. et al. Human Umbilical Cord Blood-Derived CD133+Cells Enhance function and Repair of the Infarcted Myocardium. Stem Cells 2006; 24: 772-80.

[35] Petropoulou A.D., Bellochine R., Norol F. et al. Coronary artery spasm after infusion of cryopreserved cord blood cells. Bone Marrow Transplantation 2007; 40: 397-8.

[36] MoelkerA. D., BaksT.,WeverK. etal. Intracoronary deliveryofumbilical cord blood derived unrestricted somatic stem cells is not suitable to improve LV function after myocardial infarction in swine. Journal of Molecular and Cellular Cardiology 2007; 42(4): 735-45.

[37] Kim B.O., Tian H., Prasongsukarn K. et al. Cell transplantation improves ventricular function after a myocardial infarction: a preclinical study of human unrestricted somatic stem cells in a porcine model. Circul. 2005; 112(9 Suppl): 196-1104.

[38] Finney M.R., Greco N.J., Haynesworth S.E. et al. Direct comparison of umbilical cord blood versus bone marrow-derived endothelial precursor cells in mediating neovascularization in response to vascular ischemia. Biol. Blood Bone Marrow Transplant. 2006;12[5): 585-93.

[39] Nagano M., Yamashita T., Hamada H. et al. Identification of functional endothelial progenitor cells suitable for the treatment of ischemic tissue using human umbilical cord blood. Blood 2007; 110[1): 151-160.

[40] http://www.clinicaltrials.gov/ct/show/NCTOO518934?order=33.

[41] Sanberg, P.R., Willing A.E., Garbuzova-Davis S. et al. Umbilical cord blood- derived stem cells and brain repair. Ann. N Y Acad. Sei. 2005; 1049: 67-83.

[42] Enzmann G.U., Benton R.L., Talbott J.F. et al. Functional considerations of stem cell transplantation therapy for spinal cord repair. J. Neurotrauma 2006; 23: 479-95.

[43] Dasari V. R., Spomar D.G., Gondi C. S. et al. Axonal Remyelination by Cord Blood Stem Cells after Spinal Cord Injury. J. Neurotrauma 2007; 24: 2.

[44] Walczak P. ,Chen N., Eve D. et al. Long-term cultured human umbilical cord neural-like cells transplanted into the striatum of NOD SCID mice. Brain Research Bulletin 2007; 74(14): 155-163.

[45] Nishio Y., Koda M., KamadaT. et al. The use of hemopoietic stem cells derived from human umbilical cord blood to promote restoration of spinal cord tissue and recovery of hindlimb function in adult rats. J. Neurosurg. Spine 2006; 5(5): 424-33.

[46] Lim J.-H., ByeonY.-N., Ryu H.-H. et al. Transplantation of canine umbilical cord blood-derived mesenchymal stem cells in experimentally induced spinal cord injured dogs. J Vet Soi 2007; 8(3): 275-82.

[47] http://www.olinioaltrials.gov/ot/show/NCTOO3O5344Forder-28.

[48] Pessina A., Eletti B., Croera C. et al. Pancreas developing markers expressed on human monoucleated umbilical cord blood cells. Biochem .Biophys. Res. Commun. 2004; 323: 315-22.

[49] Sun В., Roh К.-H., Lee S.-R. et al. Induction of human umbilical cord blood- derived stem cells with embryonic stem cell phenotypes into insulin producing islet-like structure. Biochemical and Biophysical Research Communications 2007;354:919-23.

[50] Yoshida S., Ishikawa F., Kawano N. et al. Human cord blood-derived cells generate insulin-producing cells in vivo. Stem Cells 2005; 23:1409-16.

[51] Naruse K., Hamada Y., Nakashima E. et al. Cord blood stem cells: Therapeutic neovascularization using cord blood-derived endothelial progenitor cells for diabetic neuropathy. Diabetes 2005; 54:1823-28.

[52] Koblas T., Harman S.M., Saudek F. The Application of Umbilical Cord Blood Cells in the Treatment of Diabetes Mellitus. Rev. Diabetic Stud .2005; 2: 228-34.

[53] Kakinuma K., Asahina K., Okamura et al. Human Cord Blood Cells Transplanted Into Chronically Damaged Liver Exhibit Similar Characteristics to Functional Hepatocytes. Transplantation Proceedings 2007; 39: 240-43.

[54] Fujino H., Hiramatsu H., Tsuchiya A. et al. Human cord blood CD34+ cells develop into hepatocytes in the livers of N0D/SCID/{gamma}cnull mice through cell fusion. FASEB J. 2007; 21: 3499-510.

[55] Sharma A. D., Cantz T., Richter R. et al. Human Cord Blood Stem Cells Generate Human Cytokeratin 18-Negative Hepatocyte-Like Cells in Injured Mouse Liver. Amer. J. of Pathol. 2005; 167: 555-64.

[56] Wang Y., Nan X., Li Y. et al. Induction of umbilical cord blood-derived beta2m-c-Met+ cells into hepatocyte-like cells by coculture with CFSC/HGF cells. Liver Transplant. 2005; 11(6): 635-43.

[57] Szabolcs P., Park K.D., Reese M. et al. Coexistent naive phenotype and higher cycling rate of cord blood T cells as compared to adult peripheral blood. Exp. Hematol. 2003; 31: 708-14.

[58] Bacchetta R., Bigler M., Touraine J.L. et al. High levels of interleukin 10 production in vivo are associated with tolerance in SCID patients transplanted with HLA mismatched hematopoietic stem cells. J. Exp. Med. 1994; 179: 493-502.

[59] Barker J.N., Weisdorf D.J., Defor T.E. et al. Umbilical cord blood [UCB) transplantation after nonmyeloablative [NMA) conditioning for advanced follicular lymphoma, mantle cell lymphoma and chronic lymphocytic leukemia: low transplant- related mortality and high progression-free survival. Blood 2005; 106: 813.

[60] Fernandes J., Rocha V., Robin M. et al. Second transplant with two unrelated cord blood units for early graft failure after haematopoietic stem cell transplantation. Brit. J. of Haematol. 2007; 137: 248-51.

[61] Barker J.N., Krepski T.P., DeForT.E. et al. Searching for unrelated donor hematopoietic stem cells: availability and speed of umbilical cord blood versus bone marrow. Biology of Blood and Marrow Transplantation 2002; 8: 257-60.

[62] Barker J.N., Weisdorf D.J., DeForT.E. et al. Transplantation of 2 partially HLA-matched umbilical cord blood units to enhance engraftment in adults with hematologic malignancy. Blood 2005; 105: 1343-47.

[63] Vemeris M.R., Brunstein C., DeFor T.E. et al. Risk of relapse [REL) after umbilical cord blood transplantation [UCBT) in patients with acute leukemia: marked reduction in recipients of two units. Blood 2005; 106: 93a.

[64] 64.http://www.clinicaltrials.gov/ct/show/NCTOO469729?order=37.

[65] Wiktor-Jedrzejczak W., Rokicka M., Urbanowska E. et al. Simultaneous transplantation of three cord blood units in adults with high risk acute leukemia. Blood 2005; 106:451b.

[66] Brunstein C.G., Barker J.N., DeFor T. et al. Non-myeloabaltive [NMA) umbilical cord blood transplantation [UCBT): promising disease-free survival in 95 consecutive patients. Blood 2005; 106:166a.

[67] Morii T., Amano I., Tanaka H. et al. Reduced-intensity unrelated cord blood transplantation [RICBT) in adult patients with high-risk hematological malignancies. Blood 2005; 106: 444b.

[68] Rio B., Belhocine R., Renaud M. et al. Reduced intensity conditioning regimen for unrelated cord blood transplantation in adults. A multicentric phase l-ll trial. Blood 2005; 106:1018a.

[69] Jacobsohn D.A., Hewlett B., Ranalli M. et al. Outcomes of unrelated cord blood transplants and allogeneic-related hematopoietic stem cell transplants in children with high-risk acute lymphocytic leukemia. Bone Marrow Transplant. 2004; 34: 901-07.

[70] Godfrey W.R., Spoden D.J., Ge Y.G. et al. Cord blood CD4+CD25+-derived T regulatory cell lines express FoxP3 protein and manifest potent suppressor function. Blood 2005; 105: 750-58.

[71] Fernandez M.N., Regidor C., Cabrera R. et al. Unrelated umbilical cord blood transplants in adults: early recovery of neutrophils by supportive cotransplantation of a low number of highly purified peripheral blood CD34 cells from an HLA-haploidentical donor. Exp. Hematol. 2003; 31: 535-44.

RIGHTS & PERMISSIONS

Eco-Vector